Skip to main content
Clinical Trials/CTRI/2021/12/038761
CTRI/2021/12/038761
Completed
Phase 2

A Single arm clinical Study to assess the efficacy of Sarodaka in Prameha

Dr Deeksha Katna0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E349- Endocrine disorder, unspecifiedHealth Condition 2: E889- Metabolic disorder, unspecified
Sponsor
Dr Deeksha Katna
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 13, 2022
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Deeksha Katna

Eligibility Criteria

Inclusion Criteria

  • Age group between 20\-60 yrs. of either sex, irrespective of religion , socio\-economic status will be selected .
  • Already diagnosed patients with Prameha.
  • Patient willing to participate.

Exclusion Criteria

  • Patients with other systemic diseases.
  • Unwilling to participate.

Outcomes

Primary Outcomes

Not specified

Similar Trials